Related Experiment Video
Updated: May 10, 2026
11:35
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population
Summary
STAT4 gene single-nucleotide polymorphisms are associated with systemic sclerosis (SSc) in Han Chinese. Specific STAT4 variants link to diffuse cutaneous SSc and pulmonary fibrosis, but not limited cutaneous SSc.
Area of Science:
- Immunogenetics
- Rheumatology
- Population Genetics
Background:
- Systemic sclerosis (SSc) is a complex autoimmune disease with a significant genetic component.
- Previous studies indicated associations between STAT4 gene single-nucleotide polymorphisms (SNPs) and SSc in various ethnic groups.
- This study investigated STAT4 SNPs in a Han Chinese population to assess their role in SSc susceptibility and clinical subsets.
Discussion:
- The study examined three STAT4 SNPs (rs7574865, rs10168266, rs3821236) in 453 SSc patients and 534 controls.
- T-allele carriers of rs7574865 and rs10168266 showed a strong association with anti-topoisomerase I (ATA) antibodies and pulmonary fibrosis in SSc.
- These STAT4 variants were also linked to diffuse cutaneous SSc (dcSSc), but not anti-centromere antibody (ACA)-positive limited cutaneous SSc (lcSSc).
Key Insights:
- STAT4 gene polymorphisms contribute to SSc susceptibility in the Han Chinese population.
- Specific STAT4 SNPs are associated with distinct clinical manifestations, including ATA positivity, pulmonary fibrosis, and dcSSc.
- The findings highlight ethnic-specific genetic influences on SSc pathogenesis and subset development.
Outlook:
- Further research is warranted to elucidate the functional mechanisms by which STAT4 variants influence SSc.
- Investigating STAT4 in diverse ethnic cohorts can refine our understanding of global SSc genetics.
- These genetic insights may inform future diagnostic and therapeutic strategies for SSc subsets.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...